Company: Merck KGaA
Job title: Principal Scientist, Early Formulation Screening Service, Life Science Services
Eleni Samaridou, PhD, is a Principal Scientist in the Early Formulation Screening Service team, part of the globally integrated mRNA-LNP CDMO offering at Merck KGaA, Darmstadt, Germany. She is a chemical engineer by training and holds a MSc in Biochemistry and a PhD in Chemical Engineering with a focus on Nanomedicine, followed by 3 years postdoctoral research experience on advanced drug delivery. Eleni brings over 6 years of hands-on experience on the development of lipid-based formulations for RNA delivery applications, having served previously as Scientist at BioNTech SE, Mainz, Germany, and, at Genevant Sciences, Vancouver, Canada.
Insights into our Fully Integrated CDMO Offering: From mRNA Manufacturing to LNP Formulation Development 4:15 pm
For more information on this session, please download the full event guide.Read more
day: Day One